Expressions of interest for the second round of CUREator+ are now open! Delivered in partnership by Brandon BioCatalyst and ANDHealth, CUREator+ supports the translation and commercial development of promising biomedical and digital health technologies.
Up to $5M non-dilutive funding is available to support breakthrough technologies to drive clinical and commercial impact through preventing, monitoring, managing, diagnosis or treatment of a disease state, its symptoms or risk factors, across three modalities:
- Medical and connected device technologies.
- Digital health technologies.
- Therapeutics.
Successful applicants will also receive:
- Commercial capability-building coaching.
- Hands-on support from the ANDHealth and Brandon BioCatalyst teams.
- Access to a global network of experts.
- Connections to pharmaceutical companies, venture capital firms and institutional investors.
Join us at our upcoming information sessionto learn all about the program, expression of interest process and selection criteria.
CUREator+ Information Session
Time: 12:00 pm 1:00 pm (AEDT)
Date: Monday 28 October 2024
Location: Online via Zoom
Click here to register
Expressions of interest will close on 4 December 2024 at 12:00pm (AEDT).
CUREator+ is delivered in partnership with Brandon BioCatalyst and supported by funding from the Medical Research Future Fund (MRFF) BioMedTech Incubator (BMTI) program.